Management of Anemia After Bariatric Surgery

Diagnostic Evaluation and Treatment

The American College of Cardiology and other guideline societies recommend managing anemia after bariatric surgery with routine iron supplementation (40-60 mg elemental iron daily), vitamin B12 replacement (intramuscular hydroxocobalamin if deficient), and folate supplementation, with intravenous iron reserved for patients who fail oral therapy or have severe deficiency 1, 2
Measure hemoglobin, mean cell volume (MCV), serum ferritin, transferrin saturation (TSAT), vitamin B12, and folate levels to diagnose anemia after bariatric surgery 1, 2
Iron deficiency anemia is characterized by low hemoglobin, low MCV, ferritin <15 μg/L (or <50 μg/L if inflammation present), and TSAT <20% 1, 3
Vitamin B12 deficiency is characterized by low hemoglobin and elevated MCV (macrocytic anemia) 1
Folate deficiency is characterized by low hemoglobin and elevated MCV 1

Oral iron therapy (40-60 mg elemental iron daily in divided doses) is first-line for mild-to-moderate anemia, but switch to intravenous iron if oral iron fails after 4-6 weeks, or if severe anemia (hemoglobin <10 g/dL) is present 2, 3
For B12 deficiency without neurological symptoms, administer hydroxocobalamin 1 mg intramuscularly three times weekly for 2 weeks, then 1 mg intramuscularly every 2-3 months for life 1
For B12 deficiency with neurological involvement, administer hydroxocobalamin 1 mg intramuscularly on alternate days until no further improvement, then 1 mg every 2 months, and seek urgent neurologist and hematologist consultation 1

All bariatric surgery patients require lifelong daily multivitamin and mineral supplementation containing thiamine (12 mg/day minimum), iron, B12, and folate 1

For patients without cardiovascular disease, hemoglobin ≥7 g/dL is generally safe and does not require transfusion, but a restrictive strategy (maintaining hemoglobin 7-9 g/dL) is preferred over liberal transfusion 4, 5, 6, 7
Patients with cardiovascular disease have significantly lower tolerance for anemia (12-fold increased mortality risk with hemoglobin 6-9 g/dL compared to those without cardiovascular disease) and may benefit from higher hemoglobin targets 4, 5, 6, 7